Dual role of the ELK3-CYFIP2 axis regulates actin dynamics and immune responses of triple-negative breast cancer during oncogenesis

被引:0
|
作者
Choi, Seung Hee [1 ]
Ryu, Ki Seo [1 ]
Park, Kyung-Soon [1 ]
Jang, Hye Jung [1 ]
机构
[1] CHA Univ, Pochon, South Korea
来源
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
基金
新加坡国家研究基金会;
关键词
D O I
10.4049/jimmunol.212.supp.0732.7489
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Edible-plant derived 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone exert dual effects on invigorating triple-negative breast cancer apoptosis
    Yu, Tingting
    Jiang, Yu
    Guo, Miaomiao
    Wei, Xing
    Xin, Xiujuan
    An, Faliang
    FOOD BIOENGINEERING, 2024, 3 (02): : 222 - 235
  • [42] "circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer" (vol 9, e12654, 2023)
    Xu, Hao
    Fang, Mengdie
    Ye, Shuhui
    Zuo, Bowen
    Yao, Wanxin
    Ren, Juan
    Zhang, Yanmei
    HELIYON, 2023, 9 (05)
  • [43] AIbZIP/CREB3L4 Promotes Cell Proliferation via the SKP2-p27 Axis in Luminal Androgen Receptor Subtype Triple-Negative Breast Cancer
    Ito, Taichi
    Saito, Atsushi
    Kamikawa, Yasunao
    Nakazawa, Nayuta
    Imaizumi, Kazunori
    MOLECULAR CANCER RESEARCH, 2024, 22 (04) : 373 - 385
  • [44] CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
    Dongwei Dou
    Xiaoyang Ren
    Mingli Han
    Xiaodong Xu
    Xin Ge
    Yuanting Gu
    Xinxing Wang
    Song Zhao
    Cancer Cell International, 20
  • [45] CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
    Dou, Dongwei
    Ren, Xiaoyang
    Han, Mingli
    Xu, Xiaodong
    Ge, Xin
    Gu, Yuanting
    Wang, Xinxing
    Zhao, Song
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [46] Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis
    Shao, Guoli
    Fan, Xulong
    Zhang, Pusheng
    Liu, Xuewen
    Huang, Lei
    Ji, Shufeng
    CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (05) : 2183 - 2205
  • [47] Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis
    Guoli Shao
    Xulong Fan
    Pusheng Zhang
    Xuewen Liu
    Lei Huang
    Shufeng Ji
    Cell Biology and Toxicology, 2023, 39 (5) : 2183 - 2205
  • [48] XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer
    Xu, Shan
    Sun, Xin
    Luo, Leixuan
    Yang, Yang
    Guo, Qiuyan
    Tang, Sheng
    Jiang, Zhiyan
    Li, Yuzhen
    Han, Jiaqian
    Gan, Wenhui
    Yang, Feiyi
    Zhang, Xuan
    Liu, Yijun
    Sun, Chuanchuan
    He, Jie
    Liu, Meng
    Zuo, Daiying
    Zhu, Wufu
    Wu, Yingliang
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [49] SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages
    Guo, Yang
    Deng, Xinxin
    Wang, Shan
    Yuan, Yuan
    Guo, Zhengwang
    Hao, Huifeng
    Jiao, Yanna
    Li, Pingping
    Han, Shuyan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 254
  • [50] Targeting PRDX2 to inhibit tumor growth and metastasis in triple-negative breast cancer: the role of FN1 and the PI3K/AKT/SP1 pathway
    Jiawei Zhou
    Anqi Cheng
    Jianqiang Guo
    Yafeng Liu
    Xuan Li
    Maoqian Chen
    Dong Hu
    Jing Wu
    Journal of Translational Medicine, 23 (1)